Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making.

ABSTRACT:

Introduction

Treatment decisions in older adults with acute myeloid leukemia (AML) are challenging, particularly for those who are not candidates for intensive chemotherapy (IC), and the trade-offs patients, their families and physicians consider when choosing a treatment option are not well understood. This qualitative research explored the value of extending survival and the treatment decision-making process from a multi-stakeholder perspective.

Methods

Overall, 28 patients with AML (≥ 65 years old, unsuitable for IC), 25 of their relatives and 10 independent physicians from the US, UK and Canada took part in one-on-one, 60-minute qualitative interviews.

Results

Across all stakeholders, improved health-related quality of life (HRQoL), extended survival and relief of

SUBMITTER: LeBlanc TW 

PROVIDER: S-EPMC9189260 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature